Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor

  • Technology appraisal guidance
  • TA195
  • Published: 

Research recommendations coming out of this guidance

There are no research recommendations for TA195